Search Results

Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, launch a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.

Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications announces the launch of its new multiplex spatial biology assay services for rapid, whole-slide imaging and analysis of tissue sections at subcellular resolution.

Navigate BioPharma Services, Inc. in Collaboration with Partners Validate Analytical Assay for Acute Myeloid Leukemia Measurable Residual Disease (AML-MRD) Assessment.

From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.

While layoffs slowed in the second half of 2024, biopharmas including Bayer, Bristol Myers Squibb and Johnson & Johnson cut hundreds or even thousands of employees over the course of the year.

Navigate BioPharma Services, Inc. announces a strategic collaboration with BD (Becton, Dickinson and Company) to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.

Rentschler Biopharma SE announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary, effective May 1, 2024.

The closures follow Novartis’s acquisition of MorphoSys earlier this year.

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.